CDC updates immunization schedule to support individual-based COVID-19 decisions and standalone chickenpox vaccination for toddlers
WASHINGTON: The Centers for Disease Control and Prevention (CDC) has updated its adult and child immunization schedules, introducing a new individual-based decision-making approach for COVID-19 vaccination and recommending standalone varicella (chickenpox) immunization for toddlers.
The revisions reflect the latest guidance from the CDC Advisory Committee on Immunization Practices (ACIP), approved by Acting CDC Director and Deputy Secretary of Health and Human Services Jim O’Neill. The updated schedules are expected to be published on CDC.gov by October 7, 2025.
“Informed consent is back,” said Deputy Secretary O’Neill. “This change empowers healthcare providers to have open, individualized discussions with patients about vaccine benefits and risks.”
Individual-based COVID-19 vaccination decisions
The CDC’s new approach introduces shared clinical decision-making for COVID-19 vaccines. This means physicians, nurses, and pharmacists will base vaccination recommendations on each patient’s specific health profile, including underlying conditions and exposure risks — rather than applying a universal booster policy.
According to ACIP, the risk-benefit ratio is highest for individuals aged 65 and above or those with increased risk factors for severe COVID-19, such as chronic illnesses or immunocompromised conditions.
The change follows declining booster uptake — only 23% of adults received the most recent CDC-recommended booster, compared to nearly 85% who completed the primary series during Operation Warp Speed (OWS).
Standalone chickenpox vaccination for toddlers
The updated child and adolescent immunization schedule recommends separate varicella (chickenpox) vaccination for toddlers aged 12–23 months, instead of the combined MMRV (measles, mumps, rubella, and varicella) shot.
Data presented by the CDC Immunization Safety Office showed that toddlers receiving the MMRV combination faced double the risk of febrile seizures within 7–10 days post-vaccination compared to those given standalone chickenpox immunization — without any added benefit in protection.
This adjustment aims to reduce seizure risks while maintaining full immunity coverage against varicella, aligning with the CDC’s safety-first approach to pediatric vaccination.
Preserving coverage and access
Despite the move to individualized decisions, all recommended vaccines — including those guided by shared clinical decision-making — will remain covered by Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and Affordable Care Act-regulated insurance plans.
The CDC emphasized that individual-based guidance does not reduce access or coverage but ensures more personalized, evidence-based vaccination practices that reflect each patient’s unique health context.
Bottom line
The CDC’s 2025 immunization schedule represents a pivotal shift toward patient-centered vaccination, balancing safety, scientific evidence, and informed consent. By recommending standalone chickenpox immunization and tailored COVID-19 vaccination discussions, the agency seeks to enhance public trust, transparency, and long-term health protection for Americans of all ages.
Stay informed and protect your health!
CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for expert tips, health updates, and the latest medical research straight to your phone.